• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BAG-1 和 PARP-1 在人乳头瘤病毒(HPV)相关的宫颈前病变和浸润性宫颈癌中的表达。

Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV).

机构信息

Department of Pathology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Avenida dos Bandeirantes, 3900, 14049-900, Ribeirão Preto, São Paulo, Brazil.

出版信息

Pathol Oncol Res. 2012 Oct;18(4):929-37. doi: 10.1007/s12253-012-9523-y. Epub 2012 Mar 28.

DOI:10.1007/s12253-012-9523-y
PMID:22454210
Abstract

Cervical cancer remains persistently the second most common malignancies among women worldwide, responsible for 500,000 new cases annually. Only in Brazil, the estimate is for 18,430 new cases in 2011. Several types of molecular markers have been studied in carcinogenesis including proteins associated with apoptosis such as BAG-1 and PARP-1. This study aims to demonstrate the expression of BAG-1 and PARP-1 in patients with low-grade squamous intraepithelial lesions (LSILs), high-grade squamous intraepithelial lesions (HSILs) and invasive squamous cell carcinomas (SCCs) of the uterine cervix and to verify a possible association with HPV infection. Fifty samples of LSILs, 50 samples of HSILs and 50 samples of invasive SCCs of the uterine cervix were analyzed by immunohistochemistry for BAG-1 and PARP-1 expression. PCR was performed to detect and type HPV DNA. BAG-1 expression levels were significantly different between LSILs and HSILs (p = 0,014) and between LSILs and SCCs (p = 0,014). In regards to PARP-1 expression, we found significant differences between the expression levels in HSILs and SCCs (p = 0,022). No association was found between BAG-1 expression and the presence of HPV. However, a significant association was found between PARP-1 expression and HPV positivity in the HSILs group (p = 0,021). In conclusion our research suggests that BAG-1 expression could contribute to the differentiation between LSIL and HSIL/SCC whereas PARP-1 could be useful to the differentiation between HSIL HPV-related and SCC. Further studies are needed to clarify the molecular aspects of the relationship between PARP-1 expression and HPV infection, with potential applications for cervical cancer prediction.

摘要

宫颈癌仍然是全球女性中第二常见的恶性肿瘤,每年导致 50 万新发病例。仅在巴西,2011 年估计就有 18430 例新发病例。在癌变过程中,已经研究了几种类型的分子标志物,包括与细胞凋亡相关的蛋白,如 BAG-1 和 PARP-1。本研究旨在证明 BAG-1 和 PARP-1 在低级别鳞状上皮内病变(LSIL)、高级别鳞状上皮内病变(HSIL)和宫颈浸润性鳞状细胞癌(SCC)患者中的表达,并验证与 HPV 感染的可能相关性。通过免疫组织化学法分析了 50 例 LSIL、50 例 HSIL 和 50 例宫颈浸润性 SCC 组织中 BAG-1 和 PARP-1 的表达情况。采用 PCR 检测和分型 HPV DNA。LSIL 与 HSIL 之间(p=0.014)和 LSIL 与 SCC 之间(p=0.014)BAG-1 表达水平存在显著差异。关于 PARP-1 的表达,我们发现 HSIL 和 SCC 之间的表达水平存在显著差异(p=0.022)。BAG-1 表达与 HPV 存在之间未发现相关性。然而,在 HSIL 组中,PARP-1 表达与 HPV 阳性之间存在显著相关性(p=0.021)。总之,我们的研究表明 BAG-1 表达可能有助于 LSIL 与 HSIL/SCC 的区分,而 PARP-1 可能有助于区分与 HPV 相关的 HSIL 和 SCC。需要进一步研究以阐明 PARP-1 表达与 HPV 感染之间的分子关系,为宫颈癌预测提供潜在应用。

相似文献

1
Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV).BAG-1 和 PARP-1 在人乳头瘤病毒(HPV)相关的宫颈前病变和浸润性宫颈癌中的表达。
Pathol Oncol Res. 2012 Oct;18(4):929-37. doi: 10.1007/s12253-012-9523-y. Epub 2012 Mar 28.
2
Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.液基细胞学——宫颈病变诊断的新可能性。
Coll Antropol. 2010 Mar;34(1):19-24.
3
p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia.在非典型鳞状化生中检测高危型人乳头瘤病毒(HPV)时,p16INK4A免疫组化比HPV原位杂交更具优势。
Am J Surg Pathol. 2007 Jan;31(1):33-43. doi: 10.1097/01.pas.0000213347.65014.ee.
4
Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions.子宫颈病变液基细胞学样本中HPV L1衣壳蛋白和p16蛋白的免疫化学分析。
Cancer. 2008 Apr 25;114(2):83-8. doi: 10.1002/cncr.23366.
5
Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence.基因扩增与 ERBB2 和 EGFR 的免疫组化表达在宫颈癌发生中的作用。与细胞周期标志物和 HPV 存在的相关性。
Exp Mol Pathol. 2013 Oct;95(2):151-5. doi: 10.1016/j.yexmp.2013.06.011. Epub 2013 Jul 1.
6
Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.传统巴氏涂片检测中p16INK4a蛋白的免疫细胞化学染色及其与人乳头瘤病毒感染的关联。
Diagn Cytopathol. 2004 Oct;31(4):235-42. doi: 10.1002/dc.20122.
7
Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women.委内瑞拉妇女宫颈癌、低级别和高级别鳞状上皮内病变中人类乳头瘤病毒(HPV)型别分布。
Gynecol Oncol. 2011 Jun 1;121(3):527-31. doi: 10.1016/j.ygyno.2011.02.003. Epub 2011 Mar 21.
8
Low-grade squamous intraepithelial lesions of the cervix with marked cytological atypia-clinical follow-up and human papillomavirus genotyping.伴有明显细胞学异型性的宫颈低度鳞状上皮内病变——临床随访与人乳头瘤病毒基因分型
Int J Gynecol Pathol. 2007 Oct;26(4):457-62. doi: 10.1097/pgp.0b013e31802f64ab.
9
Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions.人乳头瘤病毒(HPV)阳性宫颈鳞状上皮内病变中p16、环氧化酶-2(COX-2)和表皮生长因子受体(EGFR)的免疫组化评估
Rom J Morphol Embryol. 2011;52(4):1187-94.
10
Immunochemical analysis of human papillomavirus L1 capsid protein in liquid-based cytology samples from cervical lesions.宫颈病变液基细胞学样本中人乳头瘤病毒L1衣壳蛋白的免疫化学分析
Acta Cytol. 2010 Sep-Oct;54(5):661-7. doi: 10.1159/000325229.

引用本文的文献

1
PARP inhibitors in non-ovarian gynecologic cancers.聚(ADP-核糖)聚合酶抑制剂在非卵巢妇科癌症中的应用
Ther Adv Med Oncol. 2024 Jun 12;16:17588359241255174. doi: 10.1177/17588359241255174. eCollection 2024.
2
Immunotherapies landscape and associated inhibitors for the treatment of cervical cancer.用于治疗宫颈癌的免疫疗法概况及相关抑制剂
Med Oncol. 2023 Oct 10;40(11):328. doi: 10.1007/s12032-023-02188-2.
3
Cervical cancer: a tale from HPV infection to PARP inhibitors.宫颈癌:从人乳头瘤病毒感染到聚(ADP - 核糖)聚合酶抑制剂的故事

本文引用的文献

1
Isomorph expression of BAG-1 gene, ER and PR in endometrial cancer.子宫内膜癌中 BAG-1 基因、ER 和 PR 的同形表达。
Anticancer Res. 2010 Oct;30(10):4103-8.
2
Expressions of the anti-apoptotic genes Bag-1 and Bcl-2 in colon cancer and their relationship.凋亡抑制基因 Bag-1 和 Bcl-2 在结肠癌中的表达及其关系。
Am J Surg. 2010 Sep;200(3):341-5. doi: 10.1016/j.amjsurg.2009.10.024. Epub 2010 Apr 20.
3
Cervical cancer: a preventable death.宫颈癌:一种可预防的死亡病因。
Genes Dis. 2022 Nov 10;10(4):1445-1456. doi: 10.1016/j.gendis.2022.09.014. eCollection 2023 Jul.
4
Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.利用体细胞改变作为晚期和转移性宫颈癌的治疗靶点。
Cancer Treat Rev. 2021 Jul;98:102225. doi: 10.1016/j.ctrv.2021.102225. Epub 2021 May 23.
5
Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report.奥拉帕利联合贝伐珠单抗治疗同源重组修复基因突变的复发性宫颈癌一例报道
J Med Case Rep. 2021 Apr 23;15(1):210. doi: 10.1186/s13256-021-02767-9.
6
Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.基因表达谱分析可提供 HPV 宫颈组织病理学信息,但不能预测 ART 抑制下 HIV+HPV+女性行 LEEP 后的复发/复发。
Carcinogenesis. 2019 Apr 29;40(2):225-233. doi: 10.1093/carcin/bgy149.
7
Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property.奥拉帕利调节 DNA 修复效率,使宫颈癌细胞对顺铂敏感,并表现出抗转移特性。
Sci Rep. 2017 Oct 9;7(1):12876. doi: 10.1038/s41598-017-13232-3.
8
High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer.PARP-1高表达与胃癌的肿瘤侵袭及不良预后相关。
Oncol Lett. 2016 Nov;12(5):3825-3835. doi: 10.3892/ol.2016.5169. Epub 2016 Sep 22.
9
Trial watch - inhibiting PARP enzymes for anticancer therapy.试验观察——抑制PARP酶用于抗癌治疗
Mol Cell Oncol. 2015 Jun 10;3(2):e1053594. doi: 10.1080/23723556.2015.1053594. eCollection 2016 Mar.
10
Pathogenic Network Analysis Predicts Candidate Genes for Cervical Cancer.致病网络分析预测宫颈癌的候选基因。
Comput Math Methods Med. 2016;2016:3186051. doi: 10.1155/2016/3186051. Epub 2016 Feb 29.
Rev Obstet Gynecol. 2009 Fall;2(4):240-4.
4
Cell intrinsic & extrinsic factors in cervical carcinogenesis.细胞内在和外在因素与宫颈癌的发生。
Indian J Med Res. 2009 Sep;130(3):286-95.
5
Bag-1 proteins in oral squamous cell carcinoma.口腔鳞状细胞癌中的Bag-1蛋白
Oral Oncol. 2009 Feb;45(2):94-102. doi: 10.1016/j.oraloncology.2008.07.013. Epub 2008 Sep 18.
6
Poly(adenosine diphosphate-ribose) polymerase-1 expression in cutaneous malignant melanomas as a new molecular marker of aggressive tumor.聚(二磷酸腺苷 - 核糖)聚合酶 -1 在皮肤恶性黑色素瘤中的表达作为侵袭性肿瘤的一种新分子标志物。
Pathol Oncol Res. 2009 Mar;15(1):47-53. doi: 10.1007/s12253-008-9086-0. Epub 2008 Aug 28.
7
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.Bag-1和Bcl-2在乳腺癌中的表达模式及预后价值
Breast Cancer Res. 2008;10(2):R35. doi: 10.1186/bcr1998. Epub 2008 Apr 23.
8
Immunohistochemical features of a papillary squamous cell carcinoma of the endometrium with transitional cell differentiation.具有移行细胞分化的子宫内膜乳头状鳞状细胞癌的免疫组织化学特征。
Diagn Pathol. 2007 Jul 23;2:26. doi: 10.1186/1746-1596-2-26.
9
S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining.通过抑制性消减杂交、临床蛋白质组学分析和免疫组织化学染色,S100A8被鉴定为HPV18感染的口腔鳞状细胞癌的生物标志物。
J Proteome Res. 2007 Jun;6(6):2143-51. doi: 10.1021/pr060551+. Epub 2007 Apr 24.
10
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.聚(ADP - 核糖)聚合酶 -1(PARP -1)在结直肠癌发生早期的过表达。
Eur J Cancer. 2006 Sep;42(14):2374-81. doi: 10.1016/j.ejca.2006.01.061. Epub 2006 Jun 30.